Latest Updates

Antenatal Betamethasone for Women at Risk for Late Preterm Delivery Reduces the Rate of Neonatal Respiratory Complications

ANTENATAL CORTICOSTEROIDS Adminstration of antenatal betamethasone is the standard of care for women at risk of preterm delivery; however, whether antenatal bethamethasone reduces the risk of neonatal complications in the late preterm period is unknown. This randomized controlled trial assessed the effectiveness of two doses of antenatal betamethasone in women at risk of late preterm delivery in preventing neonatal respiratory complications. The trial revealed that despite an increase in neonatal hypoglycemia among neonates whose mothers received betamethasone, the treatment effectively prevents neonatal respiratory complications.

EBNEO 2017

EBNEO 2017

Welcome to the 4th international Conference for Evidence-Based Neonatology, 10-12 November 2017, in Hyderabad India. It is now possible to register!

Read more

Membership

Membership

We welcome individuals and institutions around the world to sign up for a membership. An institutional membership grants employees to become individual members free of charge. All memberships are valid for one year. Institutions and individuals residing in developing countries, as defined by the UN, get a 50% fee discount. Read more information here on how…

Read more

About

About

The International Society for Evidence-Based Neonatology (EBNEO) is a non-profit organisation that nourishes a vision that all neonatal care should be firmly built on best available evidence. The vision includes as short a passage from research-based knowledge to implementation in neonatal care (translation), thereby improving survival, decreasing morbidities and promoting long-lasting health for newborn infants. Memberships are open for individuals and institutions from all around the world.

Read more